Acetylsalicylic_JJ
acid_NN
and_CC
sodium_NN
salicylate_NN
inhibit_VBP
LPS-induced_JJ
NF-kappa_NN
B\/c-Rel_NN
nuclear_JJ
translocation_NN
,_,
and_CC
synthesis_NN
of_IN
tissue_NN
factor_NN
-LRB-_-LRB-
TF_NN
-RRB-_-RRB-
and_CC
tumor_NN
necrosis_NN
factor_NN
alfa_NN
-LRB-_-LRB-
TNF-alpha_NN
-RRB-_-RRB-
in_IN
human_JJ
monocytes_NNS
._.

We_PRP
have_VBP
investigated_VBN
the_DT
effects_NNS
of_IN
acetylsalicylic_JJ
acid_NN
and_CC
sodium_NN
salicylate_NN
on_IN
the_DT
LPS-induced_JJ
synthesis_NN
of_IN
the_DT
pro-coagulant_JJ
protein_NN
tissue_NN
factor_NN
-LRB-_-LRB-
TF_NN
-RRB-_-RRB-
and_CC
the_DT
pro-inflammatory_JJ
protein_NN
tumor_NN
necrosis_NN
factor-alpha_NN
-LRB-_-LRB-
TNF-alpha_NN
-RRB-_-RRB-
,_,
as_RB
well_RB
as_IN
the_DT
prostaglandin_NN
PGE2_NN
in_IN
human_JJ
monocytes_NNS
._.

Both_DT
drugs_NNS
dose-dependently_RB
inhibited_VBD
LPS-induced_JJ
TF_NN
and_CC
TNF-alpha_NN
synthesis_NN
at_IN
the_DT
mRNA_NN
and_CC
the_DT
protein_NN
level_NN
,_,
and_CC
reduced_VBD
PGE2_NN
production_NN
._.

As_IN
evidenced_VBN
by_IN
electro_NN
mobility_NN
shift_NN
assay_NN
-LRB-_-LRB-
EMSA_NN
-RRB-_-RRB-
and_CC
the_DT
use_NN
of_IN
a_DT
NF-kappa_NN
B_NN
prototypic_JJ
probe_NN
,_,
these_DT
drugs_NNS
probably_RB
exert_VBP
their_PRP$
inhibitory_JJ
effects_NNS
by_IN
interference_NN
with_IN
the_DT
nuclear_JJ
translocation_NN
of_IN
NF-kappa_NN
B\/c-Rel_NN
proteins_NNS
._.

These_DT
data_NNS
may_MD
expand_VB
the_DT
understanding_NN
of_IN
the_DT
anti-thrombotic_JJ
and_CC
anti-inflammatory_JJ
effects_NNS
of_IN
these_DT
drugs_NNS
when_WRB
activation_NN
of_IN
monocytes_NNS
occurs_VBZ
._.

